StockData
Artelo Biosciences, Inc. logo

Artelo Biosciences, Inc. (ARTL) bonds

ARTLNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$1.50−0.18 (-10.71%)

Close on Nov 18, 2026Market cap $1.01MP/E –Yield –

Debt

Borrowings on the balance sheet, Jun 30, 2026

Artelo Biosciences reports no long-term debt line

Its balance sheet in XBRL does not include long-term debt, so totals and interest cost cannot be shown.

Notes and loans outstanding

As tagged in Artelo Biosciences's 10-Q for the period ended Jun 30, 2026

IssueCouponAmount issued
Boot Capital LLC–$113.00K
Labrys Fund IILP–$315.00K
Unsecured Convertible Notes
Convertible at $6 a share
12.00%–
Vanquish Funding Group Inc–$237.00K

Companies tag their debt differently: some list every note, others group notes by issuance year or by type, so the list may not add up to total debt. Notes that matured before today are hidden. Source: 10-Q.

See a number that looks wrong?